What does SAF stand for?

Symptomatic Atrial Fibrillation

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Superannuation Funds Supplementary Application Form (university admissions) Support Action Form Surficial Amorphous Films Svenska Arbetsgivareföreningen (Association of Swedish Employers) Swedish Armed Forces Swedish Employers' Confederation Swiss AIDS Federation (Zurich, Switzerland) Swiss Armed Forces Symmetry-Adapted Function		Syndrome d'Alcoolisme Foetal (French: Fetal Alcohol Syndrome) Synthetic Aperture Function System Access Fee System Administration Function System Authorization Facility Safety Level Secretary of the Air Force for Acquisition Secretary of the Air Force-Acquisition Secure Access Facility for Transactions (VINCIV Corp) SCSI Access Fault-Tolerant Enclosure

Samples in periodicals archive:

According to the Indications and Usage section of the FDA-approved PI for Rythmol SR, the product is indicated to prolong the time to recurrence of symptomatic atrial fibrillation in patients without structural heart disease.

Reliant Pharmaceuticals, Liberty Corner, NJ. Sept. 14 (DDMAC)

Other medications included oral simvastatin for hypercholesterolemia and amiodarone 200 mg orally per day for symptomatic atrial fibrillation, which occurred 18 months prior to this admission.

Low-dose amiodarone causes cirrhosis: a case report

The NDA submission is based on safety and efficacy studies that evaluated tedisamil for the rapid conversion of recent onset atrial fibrillation or atrial flutter to normal sinus rhythm in more than 1,000 patients with symptomatic atrial fibrillation or flutter.

Solvay Pharmaceuticals, Inc. Announces FDA Extension of Tedisamil ...

The first patient, a man in his early 50s, has had drug-refractory, symptomatic atrial fibrillation for more than six years.

Cardima Reports Successful Completion of First Left-Sided Atrial ...

announced today that the Food & Drug Administration (FDA) has approved BETAPACE AF(TM) (sotalol hydrochloride) for the maintenance of normal sinus rhythm (delay in time to recurrence) in patients with symptomatic atrial fibrillation and atrial flutter (AFIB/AFL) who are currently in sinus rhythm.

FDA Approves Berlex Heart Rhythm Disorder Drug -- BETAPACE AF

InControl is the leader in the development of an implantable device for the treatment of symptomatic atrial fibrillation and is the only company with an implantable atrial defibrillation device under clinical investigation.

FEATURE/EP MedSystems enters agreements with InControl